D&B Risk Analytics
Around the world, teams focused on risk management, procurement, and compliance face increasing demands to navigate the challenges posed by geopolitical and business risks. The intricacies of both domestic and international operations, alongside a myriad of regulations, significantly influence third-party risks. Therefore, it is essential for organizations to take a proactive approach in managing their relationships with third parties. This innovative platform, leveraging the D&B Data Cloud's extensive database of over 520 million global business records and more than 2 billion updates each year, serves as an AI-driven tool that continually assesses and mitigates counterparty risk. D&B Risk Analytics incorporates top-tier risk data, providing alerts on high-risk transactions and identifying connections across a billion data points, all of which empower businesses to make well-informed choices. Additionally, the platform's intelligent workflows facilitate rapid and comprehensive screening processes, ensuring timely alerts on critical business metrics. As a result, companies can enhance their risk management strategies and improve their overall operational resilience.
Learn more
RegDesk
RegDesk stands out as the leading RIMS platform enhanced by AI, tailored specifically for Medical Device, Pharmaceutical, and IVD companies.
• Our unique Regulatory Intelligence encompasses data from over 120 countries, all presented in a uniform format, and includes timely alerts regarding regulatory updates.
• With our AI-driven Application Builder, regulatory affairs teams can efficiently create and submit global applications in a fraction of the usual time.
• The Change Assessment feature enables RA teams to evaluate the implications of changes on current products and determine the necessary actions.
• Our Distributor Collaboration tool facilitates smooth workflows for communication and document sharing with external partners.
• The Standards Management function simplifies the process for RA teams to locate and oversee both international and country-specific standards.
• Additionally, our Tracking & Reporting capability empowers teams to monitor regulatory initiatives worldwide, receive notifications for renewals, and quickly compile reports on key performance indicators.
To learn more about our offerings, please explore our website.
Learn more
KuantSol
E2E modeling that integrates business insights and subject matter knowledge with data science techniques, including statistical models and machine learning, is essential for maintaining the health and competitive edge of the BFSI sector.
Models developed through KuantSol are designed for long-term usage, ensuring they remain stable, optimal, and standardized over time. Additionally, the platform provides submission-ready, standardized documentation suited for federal regulatory requirements. Executives benefit from an easily comprehensible end model, facilitated by tailored configuration options at each decision-making stage. For instance, while leading ML/AI vendors typically present a limited number of model options along with selection criteria, consulting firms may provide a broader range but require more time and expertise to navigate. In contrast, KuantSol stands out with over 150 model options available. Furthermore, KuantSol's advanced configuration capabilities streamline and automate the model development process, enhancing efficiency and effectiveness. This comprehensive approach not only improves model performance but also empowers organizations to make informed decisions rapidly.
Learn more
Pristima
Numerous laboratories house critical preclinical information, often scattered across various systems both internally and with outside partners. This fragmentation leaves team members lacking the transparency necessary for making well-informed decisions, highlighting the urgent need for a consolidated solution. Pristima offers a comprehensive digital laboratory execution platform that incorporates intelligent workflows, automated tasks, and robust data management throughout the preclinical workflow. Similarly, Xybion's preclinical platform serves as a centralized data repository while also acting as a standardized archive solution. By leveraging this platform, organizations can enhance productivity and reduce operational costs significantly. Achieving total transparency across all data platforms allows for improved visibility into existing information, enabling teams to respond effectively to current business requirements. Ultimately, efficient data management not only streamlines processes but can also expedite the submission of final SENDs at the conclusion of studies, making it a critical factor in the preclinical research framework. This integration of systems will ensure that data is not only accessible but also actionable, paving the way for more strategic decision-making.
Learn more